Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecified
Conditions
Interventions
Intervention1: ARAGWADHADI TAILA: 30 patients will be selected and treated with aragwadhadi taila as per required.
duration of study 15 days
Dose:As Per requirement
Route : Local Application
Duration
Sponsors
DR AMRUTA ARVIND NARKAR
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients having sign and symptoms of Dushta Vrana i.e.infected wound. 2.Dushta Vrana size up to 5Ã?5cms (LxB) 3.Patients of either sex will be selected. 4.The patients of age group 19 - 70 years
Exclusion criteria
Exclusion criteria: 1.Anaemic patient Hb 2.Malnourished patient (as per age, height and weight proportion) 3.Bleeding disorders (increased B.T and C.T) 4.Patient with septicemia 5.The patients suffering from systemic disease such as AIDS, Tuberculosis, Uncontrolled Diabetes mellitus, Hepatitis-B, Malignancy, Vericose ulcer, Deep vein thrombosis, Neurogenic ulcer, Leukemia, etc. 6.Any congenital diseases or abnormalities.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1)Dushta vrana (infected wound) has been explained as a stage of vrana in many classical texts. Also, Dushta vrana (infected wound) has been mentioned as a type of vrana (wound). 2)To evaluate the eshtablish safer, cost-effective aragwadhadi taila in the management of dushta vrana (infected wound)Timepoint: 15 Days of study (0,5,10,15 days) | — |
Secondary
| Measure | Time frame |
|---|---|
| Aragwadhadi Taila is effective management of dushta vranaTimepoint: 15 days of study (0,5,10,15) | — |
Countries
India
Contacts
Public ContactDR AMRUTA ARVIND NARKAR
DR D Y PATIL DEEMED TO BE UNIVERSITY
Outcome results
None listed